Offer - Urjas Oil for just ₹ 1 X
Myclin O, a prescription drug, is manufactured in various forms such as Drops. Myclin O also has some secondary and off-label uses. These are listed below.
The right dosage of Myclin O depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Myclin O have been listed ahead. Such side effects of Myclin O normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Myclin O's effect is Moderate during pregnancy and Moderate for lactating mothers. It is important to know if Myclin O has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Myclin O related warnings section.
Myclin O is contraindicated in people with pre-existing medical conditions like Heart Failure, Liver Disease, Atrial Fibrillation as it can result in adverse effects. Other contraindications of Myclin O have been discussed in the sections ahead.
Besides this, Myclin O may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Myclin O is not safe while driving, and is not addiction.
Myclin O is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Myclin O safe for pregnant women?
Myclin O can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Myclin O right away. Take your doctor's advice before taking it again.
Is the use of Myclin O safe during breastfeeding?
Breastfeeding women may feel side effects of Myclin O. If you see any side effects, stop taking Myclin O immediately and talk to your doctor. Take Myclin O again, only after your doctor's advice.
What is the effect of Myclin O on the Kidneys?
Myclin O rarely affects the kidneys.
What is the effect of Myclin O on the Liver?
Myclin O is rarely harmful for the liver.
What is the effect of Myclin O on the Heart?
Myclin O may have mild side effects on the heart. Most people will never see any effect on the heart.
Myclin O should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Myclin O unless your doctor advises you to do so -
Is this Myclin O habit forming or addictive?
Myclin O does not cause addiction.
Interaction between Food and Myclin O
When consumed with certain foods, Myclin O may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Myclin O
Taking alcohol with Myclin O can be dangerous.
No, ideally Myclin O can't be used for hemorrhoid condition because it is not an antifungal infection. Please consult a dermatologist for the better medication options.
Myclin O is a brand name of clotrimazole. It is a prescription drug that belongs to the class of medication called antifungal. It is used to treat antifungal infections such as tinea corporis (fungal infection of the skin or scalp known as ringworm), tinea cruris (fungal infection in the skin of the genitals known as Jock itch), tinea pedis (fungal infection between the toes also known as athlete's foot), cutaneous candidiasis (skin and nail fungal infection), tinea versicolor (discolored patches of skin), and vaginal candidiasis (a yeast infection of the vagina).
Myclin O should be applied topically (on the skin) and it can be taken orally. Topically, it is applied in sufficient quantity on the affected area two times in a day. Duration, of course, will vary according to antifungal infection.
No, Myclin O is an antifungal drug. It is used to treat antifungal infections such as tinea corporis (fungal infection of the skin or scalp known as ringworm), tinea cruris (fungal infection in the skin of the genitals known as Jock itch), tinea pedis (a fungal infection between the toes known as athlete's foot), cutaneous candidiasis (skin and nail fungal infection), tinea versicolor (discolored patches of skin), and vaginal candidiasis (a yeast infection of the vagina).
No, ideally Myclin O can't be used on the face but please consult a dermatologist for the better medication options.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)